Ann V. LeFever

842 total citations
32 papers, 694 citations indexed

About

Ann V. LeFever is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ann V. LeFever has authored 32 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Ann V. LeFever's work include Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (8 papers). Ann V. LeFever is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (8 papers). Ann V. LeFever collaborates with scholars based in United States, Canada and China. Ann V. LeFever's co-authors include Akira Funahashi, Robert L. Truitt, R L Truitt, Charles C.-Y. Shih, Lawrence G. Lum, Jie He, Jessica Voss, Lorenzo Gallon, Xuemei Huang and Joseph R. Leventhal and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Scientific Reports.

In The Last Decade

Ann V. LeFever

32 papers receiving 673 citations

Peers

Countries citing papers authored by Ann V. LeFever

Since Specialization

Citations

This map shows the geographic impact of Ann V. LeFever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann V. LeFever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann V. LeFever more than expected).

Fields of papers citing papers by Ann V. LeFever

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann V. LeFever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann V. LeFever. The network helps show where Ann V. LeFever may publish in the future.

Co-authorship network of co-authors of Ann V. LeFever

This figure shows the co-authorship network connecting the top 25 collaborators of Ann V. LeFever. A scholar is included among the top collaborators of Ann V. LeFever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann V. LeFever. Ann V. LeFever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants 2018 ·Scientific Reports ·James M. Mathew, Jessica Voss, Ann V. LeFever, Iwona Konieczna, (unknown), Jie He, Xuemei Huang, Lorenzo Gallon, Anton Skaro, Mohammed Javeed Ansari, Joseph R. Leventhal	173
2	Comparison of the TCR ζ-chain with the FcR γ-chain in chimeric TCR constructs for T cell activation and apoptosis 2002 ·Cancer Immunology Immunotherapy ·Lifen Ren‐Heidenreich, (unknown), Thomas J. Hayman, (unknown), Ann V. LeFever	26
3	Use of Anti-CD3 × Anti-HER2/neu Bispecific Antibody for Redirecting Cytotoxicity of Activated T Cells Toward HER2/neu ⁺ Tumors 2001 ·Journal of Hematotherapy & Stem Cell Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Ann V. LeFever, Lawrence G. Lum	80
4	Immune Modulation in Cancer Patients After Adoptive Transfer of Anti-CD3/Anti-CD28–Costimulated T Cells—Phase I Clinical Trial 2001 ·Journal of Immunotherapy ·Lawrence G. Lum, Ann V. LeFever, Jonathan Treisman, (unknown), John Hanson	32
5	T Cells Coactivated with Immobilized Anti-CD3 and Anti-CD28 as Potential Immunotherapy for Cancer 1999 ·Journal of Immunotherapy ·(unknown), Ann V. LeFever, (unknown), Bruce L. Levine, C H June, (unknown)	54
6	Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF. 1996 ·PubMed ·C Rosenfeld, Brian J. Bolwell, Ann V. LeFever, Robert L. Taylor, Alan F. List, (unknown), Robert H. Collins, Frank M. Andrews, (unknown), Michael W. Schuster, Debra Resta, Daniel Levitt, John Nemunaitis	26
7	Association of Increased Prostaglandin E 2 Content in Bronchoalveolar Lavage Fluid and Intrathoracic Malignancy 1994 ·CHEST Journal ·Akira Funahashi, (unknown), Ann V. LeFever	15
8	Synthesis and biological evaluation of novel potent antagonists of the bombesin/gastrin releasing peptide receptor 1992 ·Journal of Medicinal Chemistry ·Michael Mokotoff, (unknown), Lan K. Wong, Ann V. LeFever, (unknown)	5
9	Lymphokine-Activated Killer Cell Activity in Lung Cancer 1991 ·CHEST Journal ·Ann V. LeFever, Akira Funahashi	5
10	Kinetic Analysis of Human IL-2 Activated Cytotoxic Cells 1991 ·Immunopharmacology and Immunotoxicology ·Ann V. LeFever, (unknown), J. Casper, Robert L. Truitt	1
11	Phenotype and function of natural killer cells in patients with bronchogenic carcinoma. 1991 ·PubMed ·Ann V. LeFever, Akira Funahashi	25
12	Kinetic Analysis of K⁺Ion Channel Functio in Lymphokine-Activated Killer (Lak) Cells' 1990 ·Immunopharmacology and Immunotoxicology ·Ann V. LeFever, Andrejs Liepins	2
13	Elevated Prostaglandin E2 Levels in Bronchoalveolar Lavage Fluid of Patients with Bronchogenic Carcinoma 1990 ·CHEST Journal ·Ann V. LeFever, Akira Funahashi	23
14	Kinetic Analysis of Lymphokine‐Activated Killer (LAK) Cells: Lytic Parameters and Determination of LAK Cell Frequency 1989 ·Scandinavian Journal of Immunology ·Ann V. LeFever, (unknown)	11
15	Role of K ⁺ Ion Channels in Lymphokine-Activated Killer (LAK) Cell Lytic Function 1989 ·Immunopharmacology and Immunotoxicology ·Ann V. LeFever, Andrejs Liepins, Robert L. Truitt	6
16	Serotonin Modulated CA⁺⁺Dependent K⁺Channels in Alloimmune Effector Cell Lytic Function 1989 ·Immunopharmacology and Immunotoxicology ·(unknown), Ann V. LeFever, Robert L. Truitt	5
17	KINETIC ANALYSIS OF CLONED CYTOTOXIC T LYMPHOCYTE REACTIVITY AGAINST NORMAL AND LEUKAEMIC TARGET CELLS 1986 ·International Journal of Immunogenetics ·Ann V. LeFever, R L Truitt	14
18	MANIPULATION OF GRAFT-VERSUS-HOST DISEASE FOR A GRAFT-VERSUS-LEUKEMIA EFFECT AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION IN AKR MICE WITH SPONTANEOUS LEUKEMIA/LYMPHOMA1 1986 ·Transplantation ·Robert L. Truitt, Charles C.-Y. Shih, Ann V. LeFever	41
19	REACTIVITY OF IN-VITRO-EXPANDED ALLOIMMUNE CYTOTOXIC T LYMPHOCYTES and Qa-1-SPECIFIC CYTOTOXIC T LYMPHOCYTES AGAINST AKR LEUKEMIA IN VIVO1 1985 ·Transplantation ·Ann V. LeFever, Robert L. Truitt, Charles C.-Y. Shih	18
20	Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. 1983 ·The Journal of Immunology ·R L Truitt, (unknown), Ann V. LeFever, (unknown), Marco Andreani, M. M. Bortin	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact